The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 29, 2011
Filed:
Feb. 24, 2005
Frank Bennett, Cranford, NJ (US);
Raymond G. Lovey, Miami, FL (US);
Yuhua Huang, Westfield, NJ (US);
Siska Hendrata, Kenilworth, NJ (US);
Anil K. Saksena, Upper Montclair, NJ (US);
Stephane L. Bogen, Somerset, NJ (US);
Yi-tsung Liu, Morris Township, NJ (US);
F. George Njoroge, Warren, NJ (US);
Srikanth Venkatraman, Woodbridge, NJ (US);
Kevin X. Chen, Edison, NJ (US);
Mousumi Sannigrahi, Summit, NJ (US);
Ashok Arasappan, Bridgewater, NJ (US);
Viyyoor M. Girijavallabhan, Parsippany, NJ (US);
Francisco Velazquez, Clinton, NJ (US);
Latha G. Nair, Edison, NJ (US);
Frank Bennett, Cranford, NJ (US);
Raymond G. Lovey, Miami, FL (US);
Yuhua Huang, Westfield, NJ (US);
Siska Hendrata, Kenilworth, NJ (US);
Anil K. Saksena, Upper Montclair, NJ (US);
Stephane L. Bogen, Somerset, NJ (US);
Yi-Tsung Liu, Morris Township, NJ (US);
F. George Njoroge, Warren, NJ (US);
Srikanth Venkatraman, Woodbridge, NJ (US);
Kevin X. Chen, Edison, NJ (US);
Mousumi Sannigrahi, Summit, NJ (US);
Ashok Arasappan, Bridgewater, NJ (US);
Viyyoor M. Girijavallabhan, Parsippany, NJ (US);
Francisco Velazquez, Clinton, NJ (US);
Latha G. Nair, Edison, NJ (US);
Schering Corporation, Kenilworth, NJ (US);
Abstract
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.